SBFM (Sunshine Biopharma, Inc.) Stock Financials & Earnings | Market Cap Arena

SBFM (Sunshine Biopharma, Inc.) Stock Financials & Earnings | Market Cap Arena

SBFMSunshine Biopharma, Inc.

Mkt Cap$6M

Healthcare·Drug Manufacturers - Specialty & Generic·🇨🇦 Canada·NASDAQ

Revenue (TTM)$37M

Net Income (TTM)-$6M

EPS (TTM)-$9.27

Free Cash Flow (TTM)-$8M

Gross Margin33.0%

Op. Margin-17.3%

Net Margin-16.1%

FCF Margin-22.3%

P/S Ratio (TTM)0.1x

P/E Ratio (TTM)—

YoY Rev Growth+13.2%

Employees—

Earnings Reports

Next: Q4 2025 · Apr 7

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q4 22	$4M	$1M	-$23M
Q1 23	$5M	$2M	-$2M
Q2 23	$6M	$2M	-$1M
Q3 23	$6M	$2M	-$779K
Q4 23	$8M	$3M	-$1M
Q1 24	$8M	$2M	-$1M
Q2 24	$9M	$2M	-$1M
Q3 24	$8M	$3M	-$1M
Q4 24	$10M	$3M	-$2M
Q1 25	$9M	$3M	-$1M
Q2 25	$9M	$3M	-$2M
Q3 25	$9M	$3M	-$1M

Valuation

Quarter	P/S	P/E
Q4 22	1.3x	—
Q1 23	0.6x	—
Q2 23	0.4x	—
Q3 23	0.3x	—
Q4 23	0.2x	—
Q1 24	0.2x	—
Q2 24	0.2x	—
Q3 24	0.2x	—
Q4 24	0.2x	—
Q1 25	0.2x	—
Q2 25	0.2x	—
Q3 25	0.1x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q4 22	-$2M	-$3M
Q1 23	-$2M	-$2M
Q2 23	-$4M	-$4M
Q3 23	-$457K	-$469K
Q4 23	-$3M	-$3M
Q1 24	-$3M	-$4M
Q2 24	-$5M	-$5M
Q3 24	-$1M	-$2M
Q4 24	-$3M	-$4M
Q1 25	-$2M	-$2M
Q2 25	-$1M	-$2M
Q3 25	-$728K	-$736K

Capital Expenditures

CapEx

Quarter	CapEx
Q4 22	$305K
Q1 23	$178K
Q2 23	$294K
Q3 23	$12K
Q4 23	$304K
Q1 24	$700K
Q2 24	$572K
Q3 24	$517K
Q4 24	$439K
Q1 25	$212K
Q2 25	$550K
Q3 25	$8K

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 22	+4528.9%	+7378.1%
Q1 23	+3890.4%	+399.5%
Q2 23	+3599.8%	+677.1%
Q3 23	+4386.2%	+264.0%
Q4 23	+94.9%	-67.5%
Q1 24	+54.1%	+32.3%
Q2 24	+67.3%	+60.8%
Q3 24	+41.6%	+41.6%
Q4 24	+24.9%	+31.2%
Q1 25	+18.0%	+14.7%
Q2 25	+1.2%	+8.5%
Q3 25	+11.6%	+10.1%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q4 22	$0	0.0%
Q1 23	$0	0.0%
Q2 23	$0	0.0%
Q3 23	$0	0.0%
Q4 23	$0	0.0%
Q1 24	$12K	0.2%
Q2 24	$0	0.0%
Q3 24	$0	0.0%
Q4 24	$0	0.0%
Q1 25	$0	0.0%
Q2 25	$0	0.0%
Q3 25	$0	0.0%

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q4 22	$42K	$6M	$178K
Q1 23	$433K	$3M	$128K
Q2 23	$369K	$2M	$133K
Q3 23	$238K	$2M	$242K
Q4 23	$816K	$3M	$231K
Q1 24	$222K	$3M	$198K
Q2 24	$436K	$3M	$256K
Q3 24	$126K	$3M	$283K
Q4 24	—	$5M	$203K
Q1 25	$215K	$3M	$398K
Q2 25	$196K	$4M	$202K
Q3 25	$119K	$3M	$235K

War Chest

Quarter	Cash	Short-term Investments	Total
Q4 22	$22M	$0	$22M
Q1 23	$19M	$0	$19M
Q2 23	$20M	$0	$20M
Q3 23	$19M	$0	$19M
Q4 23	$16M	$0	$16M
Q1 24	$17M	$0	$17M
Q2 24	$12M	$0	$12M
Q3 24	$12M	$0	$12M
Q4 24	$10M	$0	$10M
Q1 25	$8M	$70K	$8M
Q2 25	$10M	$0	$10M
Q3 25	$9M	$0	$9M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q4 22	23M	+11859.4%
Q1 23	11K	-100.0%
Q2 23	1M	+11408.4%
Q3 23	13K	-99.0%
Q4 23	12K	-7.0%
Q1 24	32K	+168.6%
Q2 24	50K	+55.1%
Q3 24	1M	+2450.0%
Q4 24	3M	+103.5%
Q1 25	3M	+4.8%
Q2 25	225K	-91.7%
Q3 25	5M	+1969.2%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 13	$0	3
FY 14	$0	3
FY 15	$569	3
FY 16	$0	3
FY 17	$0	9
FY 18	$50K	9
FY 19	$7K	3
FY 20	$24K	3
FY 21	$76K	3
FY 22	$1M	3
FY 23	$548K	44
FY 24	$671K	52